SCHEMBL22148776

SCHEMBL22148776

c1ccc(-c2cc(-c3ccccc3-c3c(-n4c5ccccc5c5ccccc54)c(-n4c5ccccc5c5ccccc54)nc(-n4c5ccccc5c5ccccc54)c3-n3c4ccccc4c4ccccc43)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.35
LMNA P02545 4/20 0.35
HPGD P15428 3/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPT P10636 3/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
ACHE P22303 1/20 0.34
MAPK10 P53779 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KDM4E B2RXH2 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
ALOX5 P09917 1/20 0.33
ATM Q13315 1/20 0.33
CYP3A4 P08684 1/20 0.32
GAA P10253 1/20 0.32
AGTR1 P30556 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30709490 1.00 SMN1; SMN2 (0.35) SMN1; SMN2LMNAHPGDMEN1KMT2A
SCHEMBL22148775 0.92 CYP19A1 (0.35) SMN1; SMN2LMNAHPGDMEN1KMT2A
SCHEMBL22148759 0.90 MEN1 (0.37) SMN1; SMN2LMNAHPGDMEN1KMT2A
SCHEMBL30709437 0.90 MEN1 (0.37) SMN1; SMN2LMNAHPGDMEN1KMT2A
SCHEMBL21889508 0.89 ACHE (0.37) SMN1; SMN2LMNAHPGDMEN1KMT2A
SCHEMBL30709385 0.89 TOP1 (0.40) LMNAHPGDMAPTKDM4EALDH1A1
SCHEMBL30709345 0.88 ABCG2 (0.36) SMN1; SMN2LMNAHPGDKMT2ACYP1A2
SCHEMBL22148591 0.87 MEN1 (0.39) SMN1; SMN2LMNAHPGDMEN1KMT2A
SCHEMBL30709495 0.87 KMT2A (0.42) MEN1KMT2AKDM4EL3MBTL1ATM
SCHEMBL21889491 0.86 CYP19A1 (0.39) SMN1; SMN2LMNAHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 SMN1; SMN2 1599/4885LMNA 1128/4885HPGD 1326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.